PIA MARTEN, CEO CANNOVUM AG

Benefit from the cannabis revolution

To the financial data
Important note for investors: The operating business of Cannovum AG is located in Cannovum Health eG and is not included in the pure AG figures.

Facts and figures

+
1231
%
in sales compared to fiscal 2021
10
%
of all cannabis distributing pharmacies are our regular customers
OUR VISION

In 2023, a billion market for legal cannabis will emerge in Germany. Today, Cannovum AG is already in a pole position as one of the market leaders in the medicinal cannabis segment

A commitment to the highest product quality and the satisfaction of our customers are our top priority.

Become part of the cannabis revolution and accompany us on our way as an investor, customer or partner.

>
8
Bn. €
Market potential for recreational cannabis in Germany per year*

Cannovum AG stock price

Trading Platforms
ING LogoMaxblue Logoscalable Logo
WKN
A2LQU2
ISIN
DE000A2LQU21
capital stock
2.536.200 €
Number of shares
2.536.200 Stück
STOCK EXchange
Düsseldorf, München, Hamburg, Berlin, gettex

Newsroom

Wir haben noch keine Ad Hoc Meldungen veröffentlicht.

Downloads

Company Calendar

June 2023
Release of annual financial statements Dec. 31, 2022

July 2023
Annual general meeting

September 2023
Release of half-year-financial-statements June 30, 2023

November 2022

Deutsches Eigenkapitalforum

Keine Daten verfügbar

Contact us

Erfolgreich abgesendet
Etwas ist beim absenden schief gegangen.
Klaus Madzia, CMO

Sign-Up for the investor newsletter

We keep you informed about all Cannovum news relevant to the stock.

Erfolgreich angemeldet
Etwas ist schief gegangen.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.